João Paulo Capela @jpcapela.bsky.social · 19/09/2026Very nice study! #ScienceSky #PharmSky #ToxSky #MedSky #NeuroSky 🧪 171
João Paulo Capela @jpcapela.bsky.social · 27/05/2026Discover Toxicology, the future journal for your toxicology research link.springer.com/article/10.1... #ScienceSky #PharmSky #ToxSky #MedSky #NeuroSky 🧪link.springer.comDiscover Toxicology, the future journal for your toxicology research - Discover ToxicologyDiscover Toxicology - 030
João Paulo Capela @jpcapela.bsky.social · 01/05/2026Our latest work conducted with Methylphenidate, first-line to treat ADHD: "Repeated Oral Methylphenidate Administration Evokes Changes in Brain Plasticity Proteins in Juvenile Wistar Kyoto Rats: Evidence for Sex-Related Differences" Neurochem Res 51, 90 (2026). doi.org/10.1007/s110... 000
João Paulo Capela @jpcapela.bsky.social · 26/02/2026Check our latest work on Methylphenidate, first-line pharmacotherapy for Attention Deficit Hyperactivity Disorder (ADHD). It's published open access in Neurochemical Research. doi.org/10.1007/s110... #PharmSky #ToxSky #MedSky #NeuroSky 🧪doi.orgRepeated Oral Methylphenidate Administration Evokes Changes in Brain Plasticity Proteins in Juvenile Wistar Kyoto Rats: Evidence for Sex-Related Differences - Neurochemical ResearchMethylphenidate (MPH) is first-line pharmacotherapy for Attention Deficit Hyperactivity Disorder (ADHD). Misdiagnosis and misuse raise concerns about exposing children and adolescents to MPH. This stu... 041
João Paulo Capela @jpcapela.bsky.social · 26/02/2026Discover Toxicology, published by Springer Nature, invites submissions of Reviews on hot topics in Toxicology. Full fee waiver if your article is submitted before the end of May. Please DM or contact me with any questions and request a formal invitation. link.springer.com/journal/44339link.springer.comDiscover ToxicologyDiscover Toxicology is an open access journal publishing research across all aspects of toxicology and its applications in research, development and society. ... 000
João Paulo Capela @jpcapela.bsky.social · 23/09/2025The EU is relying on Science based facts! #PharmSky #ToxSky #MedSky 🧪 1175
João Paulo Capela @jpcapela.bsky.social · 23/09/2025As autoridades de saúde Portuguesas e Europeias estão a funcionar bem. Triste caso este da FDA nos EUA associar paracetamol com autismo, descredibilizando a ciência. Na EU e em Portugal acreditamos na Ciência! www.infarmed.pt/web/infarmed... #PharmSky #MedSky #ToxSkyinfarmed.ptUso de paracetamol durante a gravidez mantém-se inalterado na UEInfarmed 020
João Paulo Capela @jpcapela.bsky.social · 29/07/2025Discover Toxicology, journal published by Springer Nature invites you to submit full-length or review articles on the “Toxicity of New Psychoactive Substances (NPS)”. Full fee waiver if your article is submitted by the end of October 2025. Please DM me for questions. link.springer.com/journal/44339link.springer.comDiscover ToxicologyDiscover Toxicology is an open access journal publishing research across all aspects of toxicology and its applications in research, development and ... 120
Reposted by João Paulo CapelaDiscover Journals @discover.springernature.com · 24/07/2025Aligning with this year's World Environment Day theme “End Plastic Pollution," Discover Toxicology has launched a topical Collection: Toxicological Impacts of Microplastics in Freshwater Ecosystems. Submission Deadline: 31 Oct 2025! bit.lyDiscover ToxicologyDiscover Toxicology is an open access journal publishing research across all aspects of toxicology and its applications in research, development and ... 001
Reposted by João Paulo CapelaSpringer Nature @springernature.com · 09/06/2025Have you taken part in Nature’s global survey of PhD students? We’ve had thousands of responses so far and would love to hear from you too. It should take no more than 15 mins and you can opt into a prize draw at the end. Survey closes 11 June. spklr.io/63320hAcC #PhDStudent 001
João Paulo Capela @jpcapela.bsky.social · 06/06/2025The European Drug Report 2025 is out. Cannabis remains by far the most commonly consumed illicit drug in EU, which is followed by Cocaine. Synthetic cathinones, which I study, are increasingly integrated into EU drug market. www.euda.europa.eu/publications... #PharmSky #ToxSky #MedSky 🧪euda.europa.euEuropean Drug Report 2025: Trends and Developments | www.euda.europa.euThe European Drug Report 2025: Trends and Developments presents the EUDA’s latest analysis of the drug situation in Europe. 010
João Paulo Capela @jpcapela.bsky.social · 06/06/2025To support World Environment Day, the journal Discover Toxicology has selected four articles related to environmental toxicology that discuss human impact on the environment. See them at: communities.springernature.com/posts/world-... #PharmSky #ToxSky #MedSky 🧪communities.springernature.comWorld Environment Day 2025Celebrating World Environment Day by showcasing our Discover Toxicology content on environmental toxicology and calling for papers 020
João Paulo Capela @jpcapela.bsky.social · 28/01/2025More one among manny in the EU! www.reuters.com/world/europe... #PharmSky #ToxSky #MedSky #NeuroSky 🧪reuters.comEU medicines agency quits X, moves to BlueskyThe European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media platform that some have criticised for its content. 18010
Reposted by João Paulo CapelaJoão Paulo Capela @jpcapela.bsky.social · 23/01/2025I'm writing about amphetamine therapeutic use on obesity. I mean d-amphetamine or the racemic mixture, not other amphetamine-like drug. Can anyone tell if amphetamine is still approved in any country for obesity or weight loss? Thanks! #Amphetamine #PharmSky #ToxSky #MedSky #NeuroSky 🧪 112
João Paulo Capela @jpcapela.bsky.social · 23/01/2025I'm writing about amphetamine therapeutic use on obesity. I mean d-amphetamine or the racemic mixture, not other amphetamine-like drug. Can anyone tell if amphetamine is still approved in any country for obesity or weight loss? Thanks! #Amphetamine #PharmSky #ToxSky #MedSky #NeuroSky 🧪 112
João Paulo Capela @jpcapela.bsky.social · 22/01/2025Our latest on Melatonin in food supplements and Medicines in Portugal. Up to 2mg is considered a food supplement, above a medicine! Food supplements contain melatonin and plant extracts and should be more carefully studied. www.scielo.br/j/bjps/a/5t5... #PharmSky #ToxSky #MedSky #NeuroSky 🧪scielo.br 051
João Paulo Capela @jpcapela.bsky.social · 21/12/2024Congratulations Vera for receiving this prestigious scientific career recognition prize! Muitos parabéns Vera por este merecido prémio de reconhecimento da tua carreira científica! 🤗🤗🤗🎉🎉🎉 🧪🔬 pt.linkedin.com/posts/vera-m...pt.linkedin.comVera Marisa Costa no LinkedIn: É com grande orgulho que recebi, no dia 18 de dezembro de 2024, o Prémio…É com grande orgulho que recebi, no dia 18 de dezembro de 2024, o Prémio Nunes Correa Verdades de Faria, atribuído pela Santa Casa da Misericórdia de Lisboa… 010
João Paulo Capela @jpcapela.bsky.social · 17/12/2024Good day for Science! Drugs should be used following solid proof of efficacy without serious adverse events. #PharmSky #ToxSky #MedSky #NeuroSky 🧪 www.science.org/content/arti...science.orgInfamous paper that popularized unproven COVID-19 treatment finally retractedStudy on hydroxychloroquine by Didier Raoult and colleagues gets pulled on ethical and scientific grounds 2203
João Paulo Capela @jpcapela.bsky.social · 13/12/2024For those interested in the anxiolytic effect of psychedelics I leave an interesting read. It seems interesting the possibility to dissociate the antianxiety effect of psychedelics from their hallucinogenic ones. #PharmSky #ToxSky #MedSky #NeuroSky 🧪 www.the-scientist.com/trippy-scien...the-scientist.comTrippy Science Unravels the Mystery of Psychedelics’ Antianxiety EffectsResearchers mimic the antianxiety effects of psychedelics by identifying and activating specific brain regions in an important step towards developing therapeutics that do not cause hallucinations. 1102
João Paulo Capela @jpcapela.bsky.social · 03/12/2024Found this recent study on MDMA #ecstasy pharmacokinetics in humans. For those interested in the therapeutic prospects in PSTD, MDMA is a potent CYP2D6 inhibitor it can have relevant drug–drug interactions. ascpt.onlinelibrary.wiley.com/doi/full/10.... #PharmSky #ToxSky #MedSky #NeuroSky 🧪ascpt.onlinelibrary.wiley.comMDMA pharmacokinetics: A population and physiologically based pharmacokinetics model‐informed analysisMidomafetamine (3,4-methylenedioxymethamphetamine [MDMA]) is under the U.S. Food and Drug Administration review for treatment of post-traumatic stress disorder in adults. MDMA is metabolized by CYP2D... 192
João Paulo Capela @jpcapela.bsky.social · 25/11/2024Concordo plenamente com a hipocrisia social. A nível universitário, por exemplo, há muita publicidade e patrocínios de bebidas alcoólicas, que a meu ver deviam ser repensados a favor da saúde pública. 000
João Paulo Capela @jpcapela.bsky.social · 22/11/2024“For scientists the network is starting to look like home.” Strongly agree. I never had so many scientist interacting with my posts like I do now in Bluesky. #PharmSky #ToxSky #MedSky #NeuroSky 🧪 www.science.org/content/arti...science.orgLike ‘old Twitter’: The scientific community finds a new home on BlueskyAfter recent changes to Elon Musk’s X, a gradual migration turns into a stampede 26913
João Paulo Capela @jpcapela.bsky.social · 21/11/2024For those in the field, look at our latest review article on: "Amphetamine and methylphenidate potential on the recovery from stroke and traumatic brain injury: a review" www.degruyter.com/document/doi... #PharmSky #ToxSky #MedSky #NeuroSky 🧪degruyter.comAmphetamine and methylphenidate potential on the recovery from stroke and traumatic brain injury: a reviewThe prevalence of stroke and traumatic brain injury is increasing worldwide. However, current treatments do not fully cure or stop their progression, acting mostly on symptoms. Amphetamine and methylp... 271
João Paulo Capela @jpcapela.bsky.social · 18/11/2024And I’m telling students to be careful about AI generated content! It seems people like more AI generated poetry…🫣🧪 www.nature.com/articles/s41...nature.comAI-generated poetry is indistinguishable from human-written poetry and is rated more favorably - Scientific ReportsScientific Reports - AI-generated poetry is indistinguishable from human-written poetry and is rated more favorably 000
João Paulo Capela @jpcapela.bsky.social · 15/11/2024New Open Access Journal from Springer Nature: Discover Toxicology. I'm a Section Editor and invite you to take a look and see if it fits within your research area. link.springer.com/journal/44339link.springer.comDiscover ToxicologyDiscover Toxicology is an open access journal publishing research across all aspects of toxicology and its applications in research, development and ... 290